ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,549.53
0.22%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Ironwood Pharmaceuticals Inc (IRWD)

  7. Ironwood Pharmaceuticals Inc (IRWD) Noticias

IRWD

Ironwood Pharmaceuticals (IRWD)

Ironwood Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IRWD
FechaHoraFuenteTítuloSímboloCompañía
25/04/202415:01Business WireIronwood Pharmaceuticals to Host First Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
28/03/202406:30Business WireIronwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)NASDAQ:IRWDIronwood Pharmaceuticals Inc
08/03/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
29/02/202405:00Business WireIronwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)NASDAQ:IRWDIronwood Pharmaceuticals Inc
23/02/202406:30Business WireIronwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
15/02/202406:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
15/02/202406:00Business WireIronwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial GuidanceNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/02/202415:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
01/02/202415:01Business WireIronwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/01/202418:00Business WireIronwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional ConstipationNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/01/202405:00Business WireIronwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial GuidanceNASDAQ:IRWDIronwood Pharmaceuticals Inc
03/01/202415:01Business WireIronwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
12/12/202315:01Business WireIronwood Announces the Completion of Squeeze-Out Merger With VectivBioNASDAQ:IRWDIronwood Pharmaceuticals Inc
21/11/202315:01Business WireIronwood Pharmaceuticals to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/11/202315:08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/11/202315:07Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/11/202306:00Business WireIronwood Pharmaceuticals Reports Third Quarter 2023 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
26/10/202315:01Business WireIronwood Pharmaceuticals to Host Third Quarter 2023 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
23/10/202306:30Business WireIronwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific MeetingNASDAQ:IRWDIronwood Pharmaceuticals Inc
16/10/202305:00Business WireIronwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition, a Phase II Study of Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon in Continuity (CIC) at United European Gastroenterology WeekNASDAQ:IRWDIronwood Pharmaceuticals Inc
05/10/202306:30Business WireIronwood to Present New Data at NASPGHAN Annual Meeting Reinforcing Impact of Linaclotide on Functional Constipation in Children and Adolescents Ages 6-17 Years-OldNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/09/202315:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:IRWDIronwood Pharmaceuticals Inc
09/08/202315:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/202306:00Business WireIronwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue GuidanceNASDAQ:IRWDIronwood Pharmaceuticals Inc
25/07/202315:01Business WireIronwood Pharmaceuticals to Host Second Quarter 2023 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/07/202315:21Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:IRWDIronwood Pharmaceuticals Inc
29/06/202307:32Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:IRWDIronwood Pharmaceuticals Inc
29/06/202307:30Business WireIronwood and VectivBio Announce the Completion of the Tender Offer for VectivBio SharesNASDAQ:IRWDIronwood Pharmaceuticals Inc
22/06/202316:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IRWDIronwood Pharmaceuticals Inc
16/06/202306:00Business WireIronwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBioNASDAQ:IRWDIronwood Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IRWD

Su Consulta Reciente

NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
AMEX
XLF
Financial Select Sector
NYSE
AXP
American Express
USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
PM
XAUUSD
Gold vs US Dollar
CCOM
OILBRENT
Brent Oil
NASDAQ
MSFT
Microsoft
FX
EURMXN
Euro vs MXN
AMEX
XLV
Health Care Select Sector
NYSE
JPM
JP Morgan Chase
AMEX
SPY
SPDR S&P 500
NASDAQ
TSLA
Tesla
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados